SIBO, H. pylori, and Candida Are Symptoms, Not Root Causes

You've been through the protocols. Maybe more than once. The antibiotics, the antifungals, the strict low-FODMAP diet that made social eating feel impossible. Things improved for a while, then the bloating came back. The brain fog returned. Your practitioner ran the same tests and found the same overgrowths.

Here is what most treatment plans never address: SIBO, H. pylori, and Candida are not the problem. They are the evidence that a problem already exists. These organisms thrive when the internal environment allows them to, and no kill protocol changes that environment.

This analysis makes the case that lasting resolution requires terrain restoration, not repeated suppression. You will learn why pathogens gain dominance in the first place, what conventional kill protocols consistently miss, and which biomarkers most standard workups never even order. From stomach acid sufficiency and bile output to HPA axis dysregulation and mineral status, the real diagnostic picture is rarely as simple as "you have an overgrowth."

If you are tired of treating the same symptoms on a rotating schedule, this is where a different conversation starts.

The Check Engine Light Problem

When your SIBO test comes back positive, the clinical instinct is to eliminate the bacteria. Rifaximin, herbal antimicrobials, low-FODMAP. Symptoms ease. Then, months later, the bloating returns, the breath test is positive again, and you are back at the beginning. This is not bad luck. It is a predictable consequence of treating a signal as though it were the source.

SIBO, H. pylori, and Candida are downstream expressions of a compromised internal environment. The NIH-indexed research on gut health and chronic digestive conditions states this plainly: gastric acid secretion and intestinal motility are the primary defences against bacterial overgrowth in the small intestine, and SIBO manifests when those defences fail. The overgrowth is the consequence, not the cause.

A 2025 study indexed on NIH platforms frames Small Intestinal Bacterial and Fungal Overgrowth within a "management perspectives" framework rather than a disease-eradication model. That terminology shift is not incidental. When authoritative research moves from "cure" language to "management" language, it is implicitly classifying these conditions as chronic symptom states arising from systemic dysfunction.

The check engine light analogy holds precisely here. Rifaximin without terrain restoration clears the warning light without touching the engine. The light comes back on because nothing underneath has changed.

Both organisms can exist at low levels without producing symptoms, their dominance signals a terrain shift, not a random invasion. The terrain shifted first.

This reframe is not semantic. It changes the entire clinical target. If SIBO is a symptom, treating it requires identifying what compromised the defences that normally prevent it, which is exactly what I explore with clients who have spent years in the symptom-management cycle. Pathogen elimination becomes one tool in a larger restoration, not the centrepiece of care.

Why Pathogens Take Hold: The Terrain Mechanisms

So what creates the conditions where these organisms stop being background noise and start causing symptoms? Five terrain failures account for the vast majority of cases.

Gastric acid insufficiency is the first and most direct. Gastric acid acts as the primary barrier against bacterial overgrowth; when output is low, organisms that should be destroyed in the stomach survive and migrate into the small intestine, where they colonise. Under normal acid conditions, bacterial concentration in the small intestine rarely exceeds 1,000 organisms per millilitre. Hypochlorhydria removes that ceiling entirely.

Bile acid insufficiency compounds the problem. Bile is antimicrobial. When the liver or gallbladder is producing or releasing bile inadequately, fat digestion stalls, transit slows, and the small intestine becomes a stagnant environment. Opportunistic bacteria and fungi thrive in exactly that kind of low-flow, nutrient-rich space.

Migrating motor complex dysfunction is the mechanism most people have never heard of. Between meals, a housekeeping wave called the MMC sweeps residual bacteria downstream. Chronic stress, dysautonomia, or structural dysfunction interrupts this cycle. When the MMC is impaired, bacteria accumulate in the small intestine regardless of what you eat or which antimicrobial you take.

Mineral depletion undermines the immune response at the tissue level. Hair Tissue Mineral Analysis (HTMA) can surface low zinc, magnesium, and copper that standard serum panels miss, minerals that are cofactors for digestive enzyme production, mucosal barrier integrity, and innate immune function. A gut lining short on zinc cannot mount an adequate local defence.

HPA axis dysregulation closes the loop. HPA axis dysregulation, trackable via DUTCH panel cortisol metabolites, impairs the immune and digestive signals the gut relies on, including the mucosal immune response and normal gastric motility. The result: pathogens are neither neutralised on arrival nor cleared by immune surveillance.

These upstream drivers don't appear on standard SIBO or H. pylori testing, which is why addressing the test result alone produces temporary relief at best.

What Kill Protocols Miss

The terrain that produced the overgrowth is still there.

Repopulation after a kill protocol is not a mystery. The conditions that allowed colonisation to develop are unchanged, so the same organisms, or different ones, re-establish within months. This is why the 1-5 year symptom history so common in this group looks like repeated failure. It is not treatment failure in a clinical sense. The terrain was simply never the target.

Low-FODMAP deserves specific attention here because it is often presented as a management strategy rather than a stopgap. It reduces symptoms by starving bacteria of fermentable carbohydrates, not by restoring the environment that let bacteria accumulate. Prolonged restriction compounds the problem: reduced microbial diversity, narrowed food tolerance, and entrenched food fear, without producing lasting resolution. Eating less is not the same as healing.

None of this means kill protocols are wrong. They are incomplete. Applied before terrain is restored, they produce a temporary window at best. Applied after terrain restoration, the same intervention can be more effective, because the immune system is better resourced, motility is clearing debris, and the gut lining is less permeable. Sequence is the variable that changes the outcome.

What Terrain Restoration Actually Looks Like

So if incomplete protocols leave the terrain intact, what does actually addressing the terrain require? The answer is sequence.

Order is not a stylistic preference here; it is a physiological requirement. If a killing phase begins before drainage and elimination pathways are functioning, clearing the byproducts of die-off becomes harder, which is why symptom flares during poorly sequenced protocols are common.

The correct clinical order moves through these phases in sequence:

1. Drainage (lymph, liver, colon): clearing exit routes before anything is mobilised

2. Stomach acid and bile support: restoring the upstream chemistry that keeps the small intestine inhospitable to overgrowth

3. Motility restoration: reactivating the migrating motor complex so the gut can clear between meals

4. Mineral repletion: replenishing the zinc, magnesium, and copper depleted by chronic stress and malabsorption

5. Nervous system regulation: calming the HPA axis dysregulation that suppresses secretory IgA and slows gastric motility

6. Gut lining repair: rebuilding mucosal integrity before any pathogen challenge

7. Targeted killing phase, only if retesting still indicates it is needed

Each phase builds the physiological foundation the next one requires. That is why a structured terrain protocol takes approximately six months, compared to a conventional four-week antibiotic course. The antibiotic course addresses one variable. The protocol addresses all of them, in the order the body can use them.

When the killing phase does arrive on restored terrain, it works differently. The immune system is better resourced, motility is actively clearing debris, and a repaired gut lining is far less permeable to recirculating toxins.

Critically, symptom improvement is not the endpoint. Retesting after the protocol, using the same functional labs that opened it, confirms whether pathogens have cleared and whether terrain markers have normalised. Discharging based on symptoms alone is how recurrence gets missed before it restarts the cycle.

The built-in endpoints matter as much as the phases themselves. Food reintroduction and supplement weaning are structured into the protocol from the start. The goal is eating freely again, not transferring from one therapeutic diet to a slightly less restrictive one indefinitely.

The Biomarkers Your Conventional Workup Probably Missed

Knowing the correct protocol sequence matters little if the tests driving it never measured the right things. Here is what most conventional GI workups leave unexamined, and why that gap explains persistent symptoms despite "normal" results.

Stomach acid output. No standard GI panel assesses gastric acid sufficiency. Low acid and high acid produce nearly identical symptoms, so hypochlorhydria is routinely misdiagnosed and treated with proton pump inhibitors. PPIs raise small intestinal pH, removing the barrier that prevents bacteria from colonising the upper gut and directly compounding SIBO risk.

Bile acid output and liver-gallbladder function. Standard liver panels measure damage markers like ALT and AST, they say nothing about functional bile output. Functional organic acid markers and stool testing can reveal bile-dependent detoxification patterns that a routine blood draw misses entirely. Poor bile flow means fat-soluble nutrients go unabsorbed and the gut environment becomes hospitable to opportunistic organisms.

Mineral status at tissue level. Serum mineral panels are tightly regulated, the body pulls from tissue reserves to keep blood values normal until depletion is severe. Tissue-level mineral testing, such as HTMA, gives a different picture of zinc, magnesium, and copper status, along with heavy metal burden that serum values routinely miss. Low zinc, magnesium, and copper at tissue level directly impairs mucosal integrity and immune defence.

Cortisol metabolites and HPA axis patterns. A single morning cortisol reading misses the pattern entirely. In high-achieving women with chronic gut symptoms, DUTCH cortisol mapping often reveals a pattern of dysregulated total versus free cortisol, a distinction a single morning reading cannot capture. That pattern indicates a taxed HPA axis suppressing secretory IgA and slowing gastric motility.

GI-MAP stool analysis. Breath tests measure gas, and stool antigens confirm pathogen presence or absence. The GI-MAP goes further: secretory IgA (mucosal immune output), elastase (pancreatic enzyme sufficiency), beta-glucuronidase (oestrogen recirculation and dysbiosis marker), and commensal bacteria ratios alongside pathogen load. That combination is a functional picture, not just a positive or negative result.

If your results came back normal but you still feel unwell, the markers that would explain why were simply never on the order form. The Root Cause Assessment at Satori maps precisely these markers before any protocol phase begins.

The Actual Starting Point

Now that you know which biomarkers to look for, the question is simpler than it might feel after years of searching: have those markers ever actually been assessed?

SIBO, H. pylori, and Candida are signals. Each one is your body communicating that something in the underlying environment has broken down. Treating the signal without reading the message it carries is precisely why symptoms return after every protocol.

If you have run breath tests, completed antimicrobial rounds, stripped your diet down to a handful of safe foods, and still relapsed, the terrain was never assessed. That is the missing step. Not a stronger antibiotic. Not a stricter elimination phase. The conditions that allowed overgrowth to establish itself in the first place were never measured, so they were never corrected, and the same conditions simply produced the same result again.

The terrain markers covered in the previous section, stomach acid, bile, minerals, cortisol pattern, secretory IgA, are the questions that determine whether any subsequent intervention will hold.

The free Root Cause Assessment at myrootcause.satorihealth.co gives you a starting picture of where your terrain stands. If you want the full map built from your specific history and labs, start with a free Root Cause Audit Call with Ksenia, where the clinical picture comes together properly.

The end goal is not a more refined management strategy. It is restoring the internal conditions under which your body regulates itself, so food is no longer a threat and gut health is no longer a full-time job.

Conclusion

The signal has been clear all along: SIBO, H. pylori, and Candida are outputs of terrain failure.

The four points worth carrying forward: pathogens need permissive conditions to thrive; kill protocols remove the overgrowth but leave those conditions intact; terrain restoration requires specific functional data, not guesswork; and the right labs make the underlying picture measurable and correctable.

If you are ready to stop cycling through protocols and start working on what actually drove the problem, take the free Root Cause Assessment or book a Root Cause Audit Call with Ksenia. Your body is not broken. It is responding logically to conditions that can be changed.